ALT-2074 (SYI-2074)

ALT-2074 · Synvista Therapeutics, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALT-2074 (SYI-2074), covering 2009-01-30 to 2009-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis [Phase 2]